Literature DB >> 33980596

Innate Antiviral Cytokine Response to Swine Influenza Virus by Swine Respiratory Epithelial Cells.

Abhijeet A Bakre1, Les P Jones1, Jackelyn Murray1, Z Beau Reneer1, Victoria A Meliopoulos2, Sean Cherry2, Stacey Schultz-Cherry2, Ralph A Tripp1.   

Abstract

Swine influenza virus (SIV) can cause respiratory illness in swine. Swine contribute to influenza virus reassortment, as avian, human, and/or swine influenza viruses can infect swine and reassort, and new viruses can emerge. Thus, it is important to determine the host antiviral responses that affect SIV replication. In this study, we examined the innate antiviral cytokine response to SIV by swine respiratory epithelial cells, focusing on the expression of interferon (IFN) and interferon-stimulated genes (ISGs). Both primary and transformed swine nasal and tracheal respiratory epithelial cells were examined following infection with field isolates. The results show that IFN and ISG expression is maximal at 12 h postinfection (hpi) and is dependent on cell type and virus genotype. IMPORTANCE Swine are considered intermediate hosts that have facilitated influenza virus reassortment events that have given rise pandemics or genetically related viruses have become established in swine. In this study, we examine the innate antiviral response to swine influenza virus in primary and immortalized swine nasal and tracheal epithelial cells, and show virus strain- and host cell type-dependent differential expression of key interferons and interferon-stimulated genes.

Entities:  

Keywords:  interferon-stimulated gene; interferons; swine influenza virus; swine nasal cells; swine tracheal cells

Mesh:

Substances:

Year:  2021        PMID: 33980596      PMCID: PMC8274599          DOI: 10.1128/JVI.00692-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

Review 1.  Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences.

Authors:  Thorsten Wolff; Stephan Ludwig
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

2.  IRF-7 is the master regulator of type-I interferon-dependent immune responses.

Authors:  Kenya Honda; Hideyuki Yanai; Hideo Negishi; Masataka Asagiri; Mitsuharu Sato; Tatsuaki Mizutani; Naoya Shimada; Yusuke Ohba; Akinori Takaoka; Nobuaki Yoshida; Tadatsugu Taniguchi
Journal:  Nature       Date:  2005-03-30       Impact factor: 49.962

Review 3.  The catcher in the RIG-I.

Authors:  Friedemann Weber
Journal:  Cytokine       Date:  2015-07-10       Impact factor: 3.861

4.  Type I interferon limits influenza virus-induced acute lung injury by regulation of excessive inflammation in mice.

Authors:  Yojiro Arimori; Risa Nakamura; Hisakata Yamada; Kensuke Shibata; Naoyoshi Maeda; Tetsuo Kase; Yasunobu Yoshikai
Journal:  Antiviral Res       Date:  2013-05-28       Impact factor: 5.970

5.  Influenza PB1-F2 Inhibits Avian MAVS Signaling.

Authors:  Yanna Xiao; Danyel Evseev; Chase A Stevens; Adam Moghrabi; Domingo Miranzo-Navarro; Ximena Fleming-Canepa; David G Tetrault; Katharine E Magor
Journal:  Viruses       Date:  2020-04-07       Impact factor: 5.048

Review 6.  Natural and Synthetic Sialylated Glycan Microarrays and Their Applications.

Authors:  Alyssa M McQuillan; Lauren Byrd-Leotis; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Front Mol Biosci       Date:  2019-09-13

Review 7.  The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections.

Authors:  Alexey A Lozhkov; Sergey A Klotchenko; Edward S Ramsay; Herman D Moshkoff; Dmitry A Moshkoff; Andrey V Vasin; Maria S Salvato
Journal:  Pathogens       Date:  2020-11-26

8.  Reduced accumulation of defective viral genomes contributes to severe outcome in influenza virus infected patients.

Authors:  Jasmina Vasilijevic; Noelia Zamarreño; Juan Carlos Oliveros; Ariel Rodriguez-Frandsen; Guillermo Gómez; Guadalupe Rodriguez; Mercedes Pérez-Ruiz; Sonia Rey; Isabel Barba; Francisco Pozo; Inmaculada Casas; Amelia Nieto; Ana Falcón
Journal:  PLoS Pathog       Date:  2017-10-12       Impact factor: 6.823

9.  Characteristics of Human OAS1 Isoform Proteins.

Authors:  Han Di; Husni Elbahesh; Margo A Brinton
Journal:  Viruses       Date:  2020-01-29       Impact factor: 5.048

10.  Cell type- and replication stage-specific influenza virus responses in vivo.

Authors:  Elizabeth J Fay; Stephanie L Aron; Marissa G Macchietto; Matthew W Markman; Katharina Esser-Nobis; Michael Gale; Steven Shen; Ryan A Langlois
Journal:  PLoS Pathog       Date:  2020-08-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.